Insulin aspart (Novorapid®)

DRUG2 trials

Sponsors

Karolinska Institutet, Novo Nordisk A/S

Conditions

DiabetesDiabetes Mellitus, Type 1Postprandial HyperglycemiaType 2 Diabetes Mellitus

Phase 1

A Trial Comparing the Pharmacokinetic Properties of Fast-acting Insulin Aspart Between Children, Adolescents and Adults With Type 1 Diabetes

CompletedNCT03407599

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 1

Start: 2018-01-08End: 2018-07-05Updated: 2019-06-19

Phase 4

Effects of Insulin Treatment on Postprandial Platelet Activation in Patients With Non-insulin-dependent Diabetes Mellitus (NIDDM)

CompletedNCT00771693

Karolinska InstitutetPostprandial Hyperglycemia, Type 2 Diabetes Mellitus

Start: 2007-05-31End: 2011-07-31Updated: 2022-05-27